METRO-PD1: Phase 1 study of nivolumab in combination with metronomic chemotherapy in children and adolescents with relapsing/refractory solid tumors
Nicolás André, Marie‐Cécile Le Deley, Clémence Leguillette, Alicia Probst, Leen Willems, Romain Travers, Isabelle Aerts, Cécile Faure‐Conter, Gabriel Revond-Riviere, Victoria Min, Birgit Geoerger, Pascal Chastagner, Natascha Entz-Werlé, Pierre Leblond
Topics & Concepts
MedicineCapecitabineCyclophosphamideRefractory (planetary science)Internal medicineNivolumabChemotherapyPopulationSurgeryAdverse effectGastroenterologyCancerImmunotherapyPhysicsColorectal cancerAstrobiologyEnvironmental healthChromatin Remodeling and CancerGlioma Diagnosis and TreatmentNeuroblastoma Research and Treatments